Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Prostate Adenocarcinoma × Adjuvants, Pharmaceutic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 3 Squamous Cell Carcinoma of Head and Neck 2 Carcinoma, Hepatocellular 2 Sarcoma, Synovial 1 Sarcoma, Ewing 1 Sarcoma 1 Rhabdomyosarcoma 1 Recurrence 1 Rectal Neoplasms 1 Prostate Adenocarcinoma 1 Osteosarcoma 1 Neuroblastoma 1 Neoplasms 1 Neoplasm, Residual 1 Nasopharyngeal Carcinoma 1 Liver Diseases 1 Liposarcoma 1 Laryngeal Neoplasms 1 Hypopharyngeal Neoplasms 1 Head and Neck Neoplasms 1 Breast Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 5 luprolide acetate gel depot 3 Radiotherapy 3 Radiosurgery 3 Radiation 3 Leuprolide 3 Goserelin 3 relugolix 2 gallium 68 PSMA-11 2 enzalutamide 2 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 2 Triptorelin Pamoate 2 radium Ra 223 dichloride 1 niraparib 1 histrelin 1 fluciclovine F-18 1 flibanserin 1 entinostat 1 darolutamide 1 bicalutamide 1 atezolizumab 1 apalutamide 1 abiraterone 1 X-Rays 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Specimen Handling 1 Salicylic Acid 1 Receptors, Bombesin 1 Radiotherapy, Image-Guided 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02175212 2020-11-20

AADLPC

Fundación de Investigación Biomédica - Hospital Universitario de La Princesa

Phase 3 Completed

362 enrolled 17 charts

Prostate Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡